Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
暂无分享,去创建一个
G. Martino | S. Pluchino | C. Tirolo | S. Caniglia | M. C. Morale | B. Marchetti | P. D’Adamo | C. Cossetti | D. Franciotta | E. Zardini | L. Andreoni | P. Serra | N. Testa | Adaoha Elizabeth Ihekwaba | F. L’Episcopo
[1] D. Borchelt,et al. Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function , 2012, Neurobiology of Aging.
[2] N. Sharpless. Hot topics in stem cells and self‐renewal: 2010 , 2010, Aging cell.
[3] C. Tirolo,et al. Glia as a turning point in the therapeutic strategy of Parkinson's disease. , 2010, CNS & neurological disorders drug targets.
[4] W. Streit,et al. Microglial Activation and Neuroinflammation in Alzheimer's Disease: A Critical Examination of Recent History , 2010, Front. Ag. Neurosci..
[5] A. Granholm,et al. A dual-hit animal model for age-related parkinsonism , 2010, Progress in Neurobiology.
[6] E. Arenas,et al. Emerging roles of Wnts in the adult nervous system , 2010, Nature Reviews Neuroscience.
[7] M. Sofroniew,et al. Astrocytes: biology and pathology , 2009, Acta Neuropathologica.
[8] V. Russell,et al. Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency. , 2009, Parkinsonism & related disorders.
[9] M. Schachner,et al. Cross‐Talk Between Stem Cells and the Dysfunctional Brain is Facilitated by Manipulating the Niche: Evidence from an Adhesion Molecule , 2009, Stem cells.
[10] M. Chesselet,et al. Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease. , 2009, Free radical biology & medicine.
[11] B. Song,et al. Reactive Astrocytes Form Scar-Like Perivascular Barriers to Leukocytes during Adaptive Immune Inflammation of the CNS , 2009, The Journal of Neuroscience.
[12] P. Monk,et al. Astrocyte function and role in motor neuron disease: A future therapeutic target? , 2009, Glia.
[13] T. Duka,et al. α‐Synuclein contributes to GSK‐3β‐catalyzed Tau phosphorylation in Parkinson's disease models , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] Yong Shen,et al. Interruption of β-Catenin Signaling Reduces Neurogenesis in Alzheimer's Disease , 2009, The Journal of Neuroscience.
[15] J. Cazareth,et al. Involvment of Cytosolic and Mitochondrial GSK-3β in Mitochondrial Dysfunction and Neuronal Cell Death of MPTP/MPP+-Treated Neurons , 2009, PloS one.
[16] K. Fabel,et al. Rostro‐Caudal Gradual Loss of Cellular Diversity Within the Periventricular Regions of the Ventricular System , 2009, Stem cells.
[17] E. Hirsch,et al. Neuroinflammation in Parkinson's disease: a target for neuroprotection? , 2009, The Lancet Neurology.
[18] M. Sikorska,et al. Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity , 2009, Neurobiology of Disease.
[19] P. Gasque,et al. The Multiple Roles of the Innate Immune System in the Regulation of Apoptosis and Inflammation in the Brain , 2009, Journal of neuropathology and experimental neurology.
[20] Y. Kan,et al. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte , 2009, Proceedings of the National Academy of Sciences.
[21] O. Lindvall,et al. Brain inflammation and adult neurogenesis: The dual role of microglia , 2009, Neuroscience.
[22] A. London,et al. Boosting T-cell immunity as a therapeutic approach for neurodegenerative conditions: The role of innate immunity , 2009, Neuroscience.
[23] M. Taketo,et al. Wnt antagonism of Shh facilitates midbrain floor plate neurogenesis , 2009, Nature Neuroscience.
[24] D. D. Di Monte,et al. Macrophage Antigen Complex-1 Mediates Reactive Microgliosis and Progressive Dopaminergic Neurodegeneration in the MPTP Model of Parkinson’s Disease1 , 2008, The Journal of Immunology.
[25] A. Storch,et al. Endogenous Regeneration in Parkinson's Disease: Do We Need Orthotopic Dopaminergic Neurogenesis? , 2008, Stem cells.
[26] Enrique M. Toledo,et al. Wnt signaling in neuroprotection and stem cell differentiation , 2008, Progress in Neurobiology.
[27] N. Inestrosa,et al. Frizzled‐1 is involved in the neuroprotective effect of Wnt3a against Aβ oligomers , 2008, Journal of cellular physiology.
[28] Jau-Shyong Hong,et al. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. , 2008, Trends in immunology.
[29] D. Chen,et al. Induction of Neurogenesis in Nonconventional Neurogenic Regions of the Adult Central Nervous System by Niche Astrocyte‐Produced Signals , 2008, Stem cells.
[30] K. Maiese,et al. The Wnt signaling pathway: aging gracefully as a protectionist? , 2008, Pharmacology & therapeutics.
[31] P. Mcgeer,et al. Glial reactions in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[32] Y. Xing,et al. A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.
[33] H. Okano,et al. β‐Catenin Signaling Promotes Proliferation of Progenitor Cells in the Adult Mouse Subventricular Zone , 2007, Stem cells.
[34] W. Streit,et al. The effects of aging, injury and disease on microglial function: a case for cellular senescence. , 2007, Neuron glia biology.
[35] K. Maiese,et al. Cellular demise and inflammatory microglial activation during beta-amyloid toxicity are governed by Wnt1 and canonical signaling pathways. , 2007, Cellular signalling.
[36] Yizheng Wang,et al. Inhibition of glycogen synthase kinase-3β protects dopaminergic neurons from MPTP toxicity , 2007, Neuropharmacology.
[37] Fumitaka Osakada,et al. Wnt Signaling Promotes Regeneration in the Retina of Adult Mammals , 2007, The Journal of Neuroscience.
[38] R. Jope,et al. Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics , 2007, Neurochemical Research.
[39] Huaxi Xu,et al. Phosphorylation of tau antagonizes apoptosis by stabilizing β-catenin, a mechanism involved in Alzheimer's neurodegeneration , 2007, Proceedings of the National Academy of Sciences.
[40] S. Przedborski,et al. Protocol for the MPTP mouse model of Parkinson's disease , 2007, Nature Protocols.
[41] Gerd Kempermann,et al. Physical exercise prevents age-related decline in precursor cell activity in the mouse dentate gyrus , 2006, Neurobiology of Aging.
[42] W. Wurst,et al. Genetic networks controlling the development of midbrain dopaminergic neurons , 2006, The Journal of physiology.
[43] R. Nusse,et al. Wnt Signaling: Multiple Pathways, Multiple Receptors, and Multiple Transcription Factors* , 2006, Journal of Biological Chemistry.
[44] F. Gage,et al. Identification of astrocyte-expressed factors that modulate neural stem/progenitor cell differentiation. , 2006, Stem cells and development.
[45] H. Okano,et al. Dynamic temporal and cell type-specific expression of Wnt signaling components in the developing midbrain. , 2006, Experimental cell research.
[46] M. Gerlach,et al. Multipotent Neural Stem Cells from the Adult Tegmentum with Dopaminergic Potential Develop Essential Properties of Functional Neurons , 2006, Stem cells.
[47] J. H. Kim,et al. Increase in Proliferation and Differentiation of Neural Progenitor Cells Isolated from Postnatal and Adult Mice Brain by Wnt-3a and Wnt-5a , 2006, Molecular and Cellular Biochemistry.
[48] C. Tirolo,et al. Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: Glia dictates resistance versus vulnerability to neurodegeneration , 2006, Neuroscience.
[49] H. Paudel,et al. Over‐expression of heme oxygenase‐1 promotes oxidative mitochondrial damage in rat astroglia , 2006, Journal of cellular physiology.
[50] N. Wood,et al. Expanding insights of mitochondrial dysfunction in Parkinson's disease , 2006, Nature Reviews Neuroscience.
[51] G. Castelo-Branco,et al. Ventral midbrain glia express region-specific transcription factors and regulate dopaminergic neurogenesis through Wnt-5a secretion , 2006, Molecular and Cellular Neuroscience.
[52] B. Fisher,et al. Behavioral motor recovery in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned squirrel monkey (Saimiri sciureus): Changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins , 2006, Journal of neuroscience research.
[53] Yaniv Ziv,et al. Microglia activated by IL-4 or IFN-γ differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells , 2006, Molecular and Cellular Neuroscience.
[54] Maria Speranza Desole,et al. Hormones Are Key Actors in Gene X Environment Interactions Programming the Vulnerability to Parkinson's Disease: Glia as a Common Final Pathway , 2005, Annals of the New York Academy of Sciences.
[55] Fred H. Gage,et al. Wnt signalling regulates adult hippocampal neurogenesis , 2005, Nature.
[56] B. Marchetti,et al. To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders? , 2005, Trends in pharmacological sciences.
[57] G. Comi,et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism , 2005, Nature.
[58] R. Lovell-Badge,et al. Open access, freely available online PLoS BIOLOGY Neuronal Migration and Ventral Subtype Identity in the Telencephalon Depend on SOX1 , 2022 .
[59] P. Salinas,et al. Signalling in neural development: WNTS in the vertebrate nervous system: from patterning to neuronal connectivity , 2005, Nature Reviews Neuroscience.
[60] Pamela Maher,et al. Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6‐methyl‐phenyl‐tetrahydropyridine toxicity , 2005, Journal of neurochemistry.
[61] Pier Andrea Serra,et al. Glucocorticoid receptor–nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia–neuron interactions , 2005, Brain Research Reviews.
[62] G. Castelo-Branco,et al. GSK-3β inhibition/β-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons , 2004, Journal of Cell Science.
[63] M. Horne,et al. Glial responses associated with dopaminergic striatal reinnervation following lesions of the rat substantia nigra , 2004, Brain Research.
[64] C. Thiele,et al. Glycogen synthase kinase 3β (GSK3β) mediates 6‐ hydroxydopamine‐induced neuronal death , 2004 .
[65] H. Gendelman,et al. Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[66] M. Youdim,et al. Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax , 2004, Neuropharmacology.
[67] G. Petzinger,et al. Tyrosine hydroxylase and dopamine transporter expression following 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced neurodegeneration of the mouse nigrostriatal pathway , 2004, Journal of neuroscience research.
[68] C. Tirolo,et al. Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1). , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[69] Rossana Migheli,et al. Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[70] P. Horner,et al. New roles for astrocytes: The nightlife of an ‘astrocyte’. La vida loca! , 2003, Trends in Neurosciences.
[71] M. Horne,et al. Timecourse of striatal re‐innervation following lesions of dopaminergic SNpc neurons of the rat , 2003, The European journal of neuroscience.
[72] Bin Liu,et al. Critical role of microglial NADPH oxidase‐derived free radicals in the in vitro MPTP model of Parkinson's disease , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[73] Angelo L. Vescovi,et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis , 2003, Nature.
[74] N. Inestrosa,et al. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by β-amyloid fibrils , 2003, Molecular Psychiatry.
[75] W. Streit. Microglia as neuroprotective, immunocompetent cells of the CNS , 2002, Glia.
[76] M. Horne,et al. The Role of Interleukin-1, Interleukin-6, and Glia in Inducing Growth of Neuronal Terminal Arbors in Mice , 2002, The Journal of Neuroscience.
[77] G. Monaco,et al. The Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induces Apoptosis in Mouse Nigrostriatal Glia , 2002, The Journal of Biological Chemistry.
[78] Fred H. Gage,et al. Astroglia induce neurogenesis from adult neural stem cells , 2002, Nature.
[79] Dong-Kug Choi,et al. Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease , 2002, The Journal of Neuroscience.
[80] M. Vila,et al. The role of glial cells in Parkinson's disease , 2001, Current opinion in neurology.
[81] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[82] Wolfgang Wurst,et al. Fate of Midbrain Dopaminergic Neurons Controlled by the Engrailed Genes , 2001, The Journal of Neuroscience.
[83] Arturo Alvarez-Buylla,et al. A unified hypothesis on the lineage of neural stem cells , 2001, Nature Reviews Neuroscience.
[84] A. Beaudet,et al. Basic fibroblast growth factor (bFGF) acts on both neurons and glia to mediate the neurotrophic effects of astrocytes on LHRH neurons in culture , 2000, Synapse.
[85] A. Patapoutian,et al. Roles of Wnt proteins in neural development and maintenance , 2000, Current Opinion in Neurobiology.
[86] M. Horne,et al. Axonal sprouting following lesions of the rat substantia nigra , 2000, Neuroscience.
[87] K. McNaught,et al. Altered Glial Function Causes Neuronal Death and Increases Neuronal Susceptibility to 1‐Methyl‐4‐Phenylpyridinium‐ and 6‐Hydroxydopamine‐Induced Toxicity in Astrocytic/Ventral Mesencephalic Co‐Cultures , 1999, Journal of neurochemistry.
[88] E. Snyder,et al. Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes , 1999, Nature Biotechnology.
[89] A. Álvarez-Buylla,et al. Interaction between astrocytes and adult subventricular zone precursors stimulates neurogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[90] Geoffrey A. Donnan,et al. Activated Macrophages and Microglia Induce Dopaminergic Sprouting in the Injured Striatum and Express Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor , 1999, The Journal of Neuroscience.
[91] A. Ho,et al. Induction of Interleukin-1 Associated with Compensatory Dopaminergic Sprouting in the Denervated Striatum of Young Mice: Model of Aging and Neurodegenerative Disease , 1998, The Journal of Neuroscience.
[92] E. Bézard,et al. Compensatory mechanisms in experimental and human Parkinsonism: towards a dynamic approach , 1998, Progress in Neurobiology.
[93] Jörg Stappert,et al. β‐catenin is a target for the ubiquitin–proteasome pathway , 1997 .
[94] William Slikker,et al. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration , 1997, Brain Research.
[95] G. Kreutzberg. Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.
[96] Y. Agid,et al. Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra , 1996, Brain Research.
[97] R. Burke,et al. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[98] T. Takeshima,et al. Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[99] J. Engele,et al. The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia [published erratum appears in J Neurosci 1992 Mar;12(3):685] , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[100] R. Burke,et al. An assessment of the validity of densitometric measures of striatal tyrosine hydroxylase-positive fibers: relationship to apomorphine-induced rotations in 6-hydroxydopamine lesioned rats , 1990, Journal of Neuroscience Methods.
[101] J. Langston,et al. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra , 1987, Brain Research.
[102] M. Abercrombie. Estimation of nuclear population from microtome sections , 1946, The Anatomical record.
[103] P. Gasque,et al. Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune regulatory proteins. , 2007, International review of neurobiology.
[104] R Kemler,et al. beta-catenin is a target for the ubiquitin-proteasome pathway. , 1997, The EMBO journal.
[105] O. Hornykiewicz,et al. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. , 1993, Advances in neurology.
[106] J. Schwarts,et al. Preparation and characterization of type 1 astrocytes cultured from adult rat cortex, cerebellum, and striatum , 1992, Glia.